Ginkgo may sensitize ovarian cancer cells to cisplatin: Antiproliferative and apoptosis-inducing effects of ginkgolide B on ovarian cancer cells

Integrative Cancer Therapies

Volumn 13, Issue 3, 2014, Pages

  Jiang, Wei ^a   Cong, Qing ^a   Wang, Yisheng ^a   Ye, Bin ^b   Xu, Congjian ^a  

^a FUDAN UNIVERSITY   (China)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

antiproliferative; apoptosis; cisplatin; Ginkgo; ovarian cancer; sensitivity

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CASPASE 3; CASPASE 8; CISPLATIN; CYCLIN D1; GINKGO BILOBA EXTRACT; GINKGOLIDE B; LACTATE DEHYDROGENASE; PROTEIN P21; PROTEIN P27; ANTINEOPLASTIC AGENT; GINKGOLIDE; LACTONE;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; FLOW CYTOMETRY; GINKGO BILOBA; HUMAN; HUMAN CELL; MTT ASSAY; OVARIAN CANCER CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING; CELL SURVIVAL; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; FEMALE; ISOLATION AND PURIFICATION; OVARIAN NEOPLASMS; PATHOLOGY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLOW CYTOMETRY; GINKGO BILOBA; GINKGOLIDES; HUMANS; LACTONES; OVARIAN NEOPLASMS;

EID: 84900820400     PISSN: 15347354     EISSN: 1552695X     Source Type: Journal    
DOI: 10.1177/1534735411433833     Document Type: Article

References (29)

1. Chan SL, Mok T. PARP inhibition in BRCA-mutated breast and ovarian cancers. Lancet. 2010 ; 376: 211-213
2. Baird RD, Tan DS, Kaye SB. Weekly paclitaxel in the treatment of recurrent ovarian cancer. Nat Rev Clin Oncol. 2010 ; 7: 575-582
3. Ferrari N, Tosetti F, De Flora S, Donatelli F, Noonan DM, Albini A. Diet-derived phytochemicals: from cancer chemoprevention to cardio-oncological prevention. Curr Drug Targets. In press ;:
4. D'Incalci M, Steward WP, Gescher AJ. Use of cancer chemopreventive phytochemicals as antineoplastic agents. Lancet Oncol. 2005 ; 6: 899-904
5. Brown LA, Riby LM, Reay JL. Supplementing cognitive aging: a selective review of the effects of ginkgo biloba and a number of everyday nutritional substances. Exp Aging Res. 2010 ; 36: 105-122
6. Kang JW, Kim JH, Song K, Kim SH, Yoon JH, Kim KS. Kaempferol and quercetin, components of Ginkgo biloba extract (EGb 761), induce caspase-3-dependent apoptosis in oral cavity cancer cells. Phytother Res. 2010 ; 24: S77 - S82
7. Feng X, Zhang L, Zhu H. Comparative anticancer and antioxidant activities of different ingredients of Ginkgo biloba extract (EGb 761). Planta Med. 2009 ; 75: 792-796
8. Pretner E, Amri H, Li W, et al. Cancer-related overexpression of the peripheral-type benzodiazepine receptor and cytostatic anticancer effects of Ginkgo biloba extract (EGb 761). Anticancer Res. 2006 ; 26: 9-22
9. Xu AH, Chen HS, Sun BC, et al. Therapeutic mechanism of ginkgo biloba exocarp polysaccharides on gastric cancer. World J Gastroenterol. 2003 ; 9: 2424-2427
10. Li W, Pretner E, Shen L, Drieu K, Papadopoulos V. Common gene targets of Ginkgo biloba extract (EGb 761) in human tumor cells: relation to cell growth. Cell Mol Biol (Noisy-le-grand). 2002 ; 48: 655-662
11. Chen Q, Yang GW, An LG. Apoptosis of hepatoma cells SMMC-7721 induced by Ginkgo biloba seed polysaccharide. World J Gastroenterol. 2002 ; 8: 832-836
12. Kim KS, Rhee KH, Yoon JH, Lee JG, Lee JH, Yoo JB. Ginkgo biloba extract (EGb 761) induces apoptosis by the activation of caspase-3 in oral cavity cancer cells. Oral Oncol. 2005 ; 41: 383-389
13. Ye B, Aponte M, Dai Y, et al. Ginkgo biloba and ovarian cancer prevention: epidemiological and biological evidence. Cancer Lett. 2007 ; 251: 43-52
14. Trope C, Kaern J. Adjuvant chemotherapy for early-stage ovarian cancer: review of the literature. J Clin Oncol. 2007 ; 25: 2909-2920
15. Aponte M, Jiang W, Lakkis M, et al. Activation of platelet-activating factor receptor and pleiotropic effects on tyrosine phospho-EGFR/Src/FAK/ paxillin in ovarian cancer. Cancer Res. 2008 ; 68: 5839-5848
16. Koltermann A, Liebl J, Furst R, Ammer H, Vollmar AM, Zahler S. Ginkgo biloba extract EGb 761 exerts anti-angiogenic effects via activation of tyrosine phosphatases. J Cell Mol Med. 2009 ; 13: 2122-2130
17. Law M, Forrester E, Chytil A, et al. Rapamycin disrupts cyclin/cyclin-dependent kinase/p21/proliferating cell nu-clear antigen complexes and cyclin D1 reverses rapamycin action by stabilizing these complexes. Cancer Res. 2006 ; 66: 1070-1080
18. Eigeliene N, Harkonen P, Erkkola R. Effects of estradiol and medroxyprogesterone acetate on expression of the cell cycle proteins cyclin D1, p21 and p27 in cultured human breast tissues. Cell Cycle. 2008 ; 7: 71-80
19. Cotter TG. Apoptosis and cancer: the genesis of a research field. Nat Rev Cancer. 2009 ; 9: 501-507
20. de Bruin EC, Medema JP. Apoptosis and non-apoptotic deaths in cancer development and treatment response. Cancer Treat Rev. 2008 ; 34: 737-749
21. Vucic D, Fairbrother WJ. The inhibitor of apoptosis proteins as therapeutic targets in cancer. Clin Cancer Res. 2007 ; 13: 5995-6000
22. Hu X, Zhang X, Qiu S, Yu D, Lin S. Salidroside induces cell-cycle arrest and apoptosis in human breast cancer cells. Biochem Biophys Res Commun. 2010 ; 398: 62-67
23. Deeb D, Gao X, Jiang H, Arbab AS, Dulchavsky SA, Gautam SC. Growth inhibitory and apoptosis-inducing effects of xanthohumol, a prenylated chalone present in hops, in human prostate cancer cells. Anticancer Res. 2010 ; 30: 3333-3339
24. Jiang S, Zu Y, Fu Y, Zhang Y, Efferth T. Activation of the mitochondria-driven pathway of apoptosis in human PC-3 prostate cancer cells by a novel hydrophilic paclitaxel derivative, 7-xylosyl-10-deacetylpaclitaxel. Int J Oncol. 2008 ; 33: 103-111
25. Riedl SJ, Shi Y. Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Biol. 2004 ; 5: 897-907
26. Kaufmann SH, Lee SH, Meng XW, et al. Apoptosis-associated caspase activation assays. Methods. 2008 ; 44: 262-272
27. Mazumder S, Plesca D, Almasan A. Caspase-3 activation is a critical determinant of genotoxic stress-induced apoptosis. Methods Mol Biol. 2008 ; 414: 13-21
28. Lee JH, Jung JY, Jeong YJ, et al. Involvement of both mitochondrial- and death receptor-dependent apoptotic pathways regulated by Bcl-2 family in sodium fluoride-induced apoptosis of the human gingival fibroblasts. Toxicology. 2008 ; 243: 340-347
29. Takemura Y, Ouchi N, Shibata R, et al. Adiponectin modulates inflammatory reactions via calreticulin receptor-dependent clearance of early apoptotic bodies. J Clin Invest. 2007: 117 375-386